(3S)-oxolan-3-amine hydrochloride → HCID 66643903、化合物
反応式
CO[C:3]([C:5]1[N:6]=[N:7][C:8]([O:11][CH2:12][C:13]2[C:14]([CH2:19][CH2:20][CH2:21][CH3:22])=[N:15][O:16][C:17]=2[CH3:18])=[CH:9][CH:10]=1)=[O:4].Cl.[O:24]1[CH2:28][CH2:27][C@H:26]([NH2:29])[CH2:25]1>>[O:24]1[CH2:28][CH2:27][C@H:26]([NH:29][C:3]([C:5]2[N:6]=[N:7][C:8]([O:11][CH2:12][C:13]3[C:14]([CH2:19][CH2:20][CH2:21][CH3:22])=[N:15][O:16][C:17]=3[CH3:18])=[CH:9][CH:10]=2)=[O:4])[CH2:25]1参加物
3
実験手順
As described for example 1e, 6-(3-butyl-5-methyl-isoxazol-4-ylmethoxy)-pyridazine-3-carboxylic acid methyl ester (110 mg, 0.36 mmol) was converted, using (S)-tetrahydrofuran-3-amine hydrochloride instead of isopropylamine, to the title compound (100 mg, 77%) which was obtained as a colourless oil after purification by chromatography (silica, 0 to 3.5% methanol in dichloromethane). MS: m/e=361.0 [M+H]+.
出典と根拠
- ORDレコード
- ord-937cdaff987b49129f978a3f9d383971
- 出典データセット
- uspto-grants-2013_04
- DOI